2026 ICD-10-CM Diagnosis Code F16.21Hallucinogen dependence, in remission
ICD-10-CM Codes›F01–F99›F10-F19›F16
- Billable — Valid for Submission
- Chronic Condition
F16.21 is a billable ICD-10-CM diagnosis code for hallucinogen dependence, in remission. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 894 through 897. Coders also document this condition as hallucinogen dependence in remission. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Mental and substance use disorders in remission.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Hallucinogen dependence in remission
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Other hallucinogen use disorder, moderate, in early remission
- Other hallucinogen use disorder, moderate, in sustained remission
- Other hallucinogen use disorder, severe, in early remission
- Other hallucinogen use disorder, severe, in sustained remission
- Phencyclidine use disorder, moderate, in early remission
- Phencyclidine use disorder, moderate, in sustained remission
- Phencyclidine use disorder, severe, in early remission
- Phencyclidine use disorder, severe, in sustained remission
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Dependence (on) (syndrome) - F19.20
- hallucinogen - F16.20
- in remission - F16.21
- Disorder (of) - See Also: Disease;
- in remission (early) (sustained) - F16.21
- in remission (early) (sustained) - F16.21
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Dependence(on) (syndrome)
- drug NEC
- hallucinogen
- in remission
- Disorder(of)
- hallucinogen use
- moderate or severe
- in remission (early) (sustained)
- Disorder(of)
- phencyclidine use
- moderate or severe
- in remission (early) (sustained)
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Hallucinogen Dependence
a drug dependence for a hallucinogenic substance.Hallucinogen Dependence with Hallucinogen Persisting Perception Disorder|Hallucinogen dependence with hallucinogen persisting perception disorder
evidence of hallucinogen dependence with hallucinogen persisting perception disorder.Hallucinogen Dependence with Hallucinogen-Induced Anxiety Disorder|Hallucinogen dependence with hallucinogen-induced anxiety disorder
evidence of hallucinogen dependence with hallucinogen-induced anxiety disorder.Hallucinogen Dependence with Hallucinogen-Induced Mood Disorder|Hallucinogen dependence with hallucinogen-induced mood disorder
evidence of hallucinogen dependence with hallucinogen-induced mood disorder.Hallucinogen Dependence with Hallucinogen-Induced Psychotic Disorder with Delusions|Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions
evidence of hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions.Hallucinogen Dependence with Hallucinogen-Induced Psychotic Disorder with Hallucinations|Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations
evidence of hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations.Hallucinogen Dependence with Hallucinogen-Induced Psychotic Disorder, Unspecified|Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified
evidence of hallucinogen dependence with hallucinogen-induced psychotic disorder.Hallucinogen Dependence with Intoxication with Delirium|Hallucinogen dependence with intoxication with delirium
evidence of hallucinogen dependence with intoxication with delirium.Hallucinogen Dependence with Intoxication, Uncomplicated|Hallucinogen dependence with intoxication, uncomplicated
evidence of hallucinogen dependence with intoxication, uncomplicated.Hallucinogen Dependence with Intoxication, Unspecified|Hallucinogen dependence with intoxication, unspecified
evidence of hallucinogen dependence with intoxication.Hallucinogen Dependence with Other Hallucinogen-Induced Disorder|Hallucinogen dependence with other hallucinogen-induced disorder
evidence of hallucinogen dependence with other hallucinogen-induced disorder.Hallucinogen Dependence with Unspecified Hallucinogen-Induced Disorder|Hallucinogen dependence with unspecified hallucinogen-induced disorder
evidence of hallucinogen dependence with unspecified hallucinogen-induced disorder.Hallucinogen Dependence, Continuous Use
physical and psychological dependence on hallucinogenics, which is associated with a pattern of continuous use.Hallucinogen Dependence, Episodic Use
physical and psychological dependence on hallucinogenics, which is associated with a pattern of episodic use.Hallucinogen Dependence, in Remission|Hallucinogen dependence, in remission
evidence of hallucinogen dependence, in remission.Hallucinogen Dependence, Uncomplicated|Hallucinogen dependence, uncomplicated
evidence of hallucinogen dependence, uncomplicated.
Patient EducationClinical
Drug Use and Addiction
Drugs are chemical substances that can change how your body and mind work. They include prescription medicines, over-the-counter medicines, alcohol, tobacco, and illegal drugs.
The full article covers:
- What are drugs?
- What is drug use?
- What is drug addiction?
- Does everyone who takes drugs become addicted?
- Who is at risk for drug addiction?
- What are the signs that someone has a drug problem?
- What are the treatments for drug addiction?
- Can drug use and addiction be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert F16.21 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About F16.21Overview
Is F16.21 (Hallucinogen dependence) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report hallucinogen dependence, in remission on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does F16.21 group to?
When hallucinogen dependence, in remission is the principal diagnosis on an inpatient stay, it groups to MS-DRG 894, 895, 896, 897, with relative weights from 0.6169 to 1.7451 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of F16.21?
Under the General Equivalence Mappings, hallucinogen dependence, in remission converts to ICD-9-CM 304.53 (hallucinogen dep-remiss). The mapping is a direct match.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
